Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128760) titled 'Observational Study on the Efficacy of Brentuximab Vedotin-Based Therapies for Cutaneous T-Cell Lymphoma (CTCL) and an Exploration of Factors Affecting Treatment Outcomes' on July 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Huashan Hospital affiliated to Fudan university
Condition:
primary cutaneous T-cell Lymphoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: BV-Based therapy group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333812
Disclaimer: Curate...